These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11948536)

  • 1. Oral mucosal absorption of midazolam in dogs is strongly pH dependent.
    Zhang J; Niu S; Zhang H; Streisand JB
    J Pharm Sci; 2002 Apr; 91(4):980-2. PubMed ID: 11948536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buccal absorption of etomidate from a solid formulation in dogs.
    Zhang J; Maland L; Hague B; Niu S; Robertson S; Coleman D; Stanley TH; Streisand JB
    Anesth Analg; 1998 May; 86(5):1116-22. PubMed ID: 9585308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buccal absorption of fentanyl is pH-dependent in dogs.
    Streisand JB; Zhang J; Niu S; McJames S; Natte R; Pace NL
    Anesthesiology; 1995 Mar; 82(3):759-64. PubMed ID: 7879944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Midazolam pharmacokinetics following intravenous and buccal administration.
    Schwagmeier R; Alincic S; Striebel HW
    Br J Clin Pharmacol; 1998 Sep; 46(3):203-6. PubMed ID: 9764959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of semisimultaneous midazolam administration for hepatic and intestinal cytochrome P450 3A phenotyping.
    Lee JI; Chaves-Gnecco D; Amico JA; Kroboth PD; Wilson JW; Frye RF
    Clin Pharmacol Ther; 2002 Dec; 72(6):718-28. PubMed ID: 12496753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and pharmacodynamics of midazolam administered as a concentrated intranasal spray. A study in healthy volunteers.
    Knoester PD; Jonker DM; Van Der Hoeven RT; Vermeij TA; Edelbroek PM; Brekelmans GJ; de Haan GJ
    Br J Clin Pharmacol; 2002 May; 53(5):501-7. PubMed ID: 11994056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buccal absorption of insulin in the dog.
    Ritschel WA; Ritschel GB; Forusz H; Kraeling M
    Res Commun Chem Pathol Pharmacol; 1989 Jan; 63(1):53-67. PubMed ID: 2644683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin.
    Gorski JC; Jones DR; Haehner-Daniels BD; Hamman MA; O'Mara EM; Hall SD
    Clin Pharmacol Ther; 1998 Aug; 64(2):133-43. PubMed ID: 9728893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum and cerebrospinal fluid concentrations of midazolam after epidural administration in dogs.
    Nishiyama T; Tamai H; Hanaoka K
    Anesth Analg; 2003 Jan; 96(1):159-62, table of contents. PubMed ID: 12505943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal absorption of flurazepam, midazolam, and triazolam in dogs.
    Lui CY; Amidon GL; Goldberg A
    J Pharm Sci; 1991 Dec; 80(12):1125-9. PubMed ID: 1815070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of midazolam given as an intranasal spray to adult surgical patients.
    Björkman S; Rigemar G; Idvall J
    Br J Anaesth; 1997 Nov; 79(5):575-80. PubMed ID: 9422893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioavailability of a novel midazolam gel after intranasal administration in dogs.
    Eagleson JS; Platt SR; Strong DL; Kent M; Freeman AC; Nghiem PP; Zheng B; White CA
    Am J Vet Res; 2012 Apr; 73(4):539-45. PubMed ID: 22452501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different absorption profiles of deramciclane in man and in dog.
    Kanerva H; Klebovich I; Drabant S; Urtti A; Nevalainen T
    J Pharm Pharmacol; 1998 Oct; 50(10):1087-93. PubMed ID: 9821653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and bioavailability of midazolam after intravenous, subcutaneous, intraperitoneal and oral administration under a chronic food-limited regimen: relating DRL performance to pharmacokinetics.
    Lau CE; Ma F; Wang Y; Smith C
    Psychopharmacology (Berl); 1996 Aug; 126(3):241-8. PubMed ID: 8876024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of oral posaconazole on the pharmacokinetic properties of oral and intravenous midazolam: a phase I, randomized, open-label, crossover study in healthy volunteers.
    Krishna G; Moton A; Ma L; Savant I; Martinho M; Seiberling M; McLeod J
    Clin Ther; 2009 Feb; 31(2):286-98. PubMed ID: 19302901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and pharmacodynamics of midazolam after intranasal administration.
    Burstein AH; Modica R; Hatton M; Forrest A; Gengo FM
    J Clin Pharmacol; 1997 Aug; 37(8):711-8. PubMed ID: 9378843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timed-release formulation to avoid drug-drug interaction between diltiazem and midazolam.
    Sawada T; Sako K; Yoshihara K; Nakamura K; Yokohama S; Hayashi M
    J Pharm Sci; 2003 Apr; 92(4):790-7. PubMed ID: 12661064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and preliminary observations of behavioral changes following administration of midazolam to dogs.
    Court MH; Greenblatt DJ
    J Vet Pharmacol Ther; 1992 Dec; 15(4):343-50. PubMed ID: 1487833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pharmacokinetic and pharmacodynamic study, in healthy volunteers, of a rapidly absorbed intranasal midazolam formulation.
    Wermeling DP; Record KA; Archer SM; Rudy AC
    Epilepsy Res; 2009 Feb; 83(2-3):124-32. PubMed ID: 19046855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacokinetics of midazolam after intravenous, intramuscular, and rectal administration in healthy dogs.
    Schwartz M; Muñana KR; Nettifee-Osborne JA; Messenger KM; Papich MG
    J Vet Pharmacol Ther; 2013 Oct; 36(5):471-7. PubMed ID: 23256899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.